Universe Pharmaceuticals (UPC) Shares Outstanding (Weighted Average) (2020 - 2024)

Universe Pharmaceuticals has disclosed Shares Outstanding (Weighted Average) across 5 years of filings, most recently posting $393260.0 for Q1 2024.

• Shares Outstanding (Weighted Average) for Q1 2024 came in at $393260.0, down 99.99% year-over-year; the trailing twelve-month figure through Mar 2024 was $393260.0 (down 99.99% YoY), and the FY2022 annual result was $6042.0, up 763.14% from the prior year.
• Shares Outstanding (Weighted Average) came in at $393260.0 for Q1 2024 at Universe Pharmaceuticals, down from $3.6 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $3.6 billion in Q1 2022 to a low of $6042.0 in Q3 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $9.6 million (2020), against an average of $1.2 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) changed 0.0% in 2023 and plunged 99.99% in 2024, its largest moves.
• Universe Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $16.0 million in 2020, then slumped by 80.23% to $3.2 million in 2021, then plunged by 99.81% to $6042.0 in 2022, then jumped by 59996589.84% to $3.6 billion in 2023, then slumped by 99.99% to $393260.0 in 2024.
• The last three Shares Outstanding (Weighted Average) figures came in at $393260.0 (Q1 2024), $3.6 billion (Q1 2023), and $6042.0 (Q3 2022), per Business Quant data.